| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ROOTRoot, Inc. | 988.1M | 72.11 | 39.40 | 158.57% | 3.95% | 21.55% | 18.61% | 0.98 |
| LMNDLemonade, Inc. | 5.99B | 80.19 | -28.14 | 22.5% | -26.39% | -33.67% | 0.18 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | 43.3M | 290.2M | 346.8M | 345.4M | 310.8M | 455M | 1.18B |
| Revenue Growth % | - | 5.7% | 0.2% | -0% | -0.1% | 0.46% | 1.59% |
| Medical Costs & Claims | 53.7M | 373.7M | 361M | 397.3M | 343M | 378.9M | 839.4M |
| Medical Cost Ratio % | - | - | - | - | - | - | - |
| Gross Profit | -10.4M | -83.5M | -14.2M | -51.9M | -32.2M | 76.1M | 337.1M |
| Gross Margin % | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -7.03% | 0.83% | -2.65% | 0.38% | 3.36% | 3.43% |
| Operating Expenses | 58.7M | 198.9M | 348.8M | 469.2M | 265.5M | 223.5M | 306.2M |
| OpEx / Revenue % | - | - | - | - | - | - | - |
| Depreciation & Amortization | 600K | 4.9M | 15.6M | 16.6M | 13.8M | 12.6M | 14.9M |
| Combined Ratio % | - | - | - | - | - | - | - |
| Operating Income | -69.1M | -282.4M | -363M | -521.1M | -297.7M | -147.4M | 30.9M |
| Operating Margin % | - | - | - | - | - | - | - |
| Operating Income Growth % | - | -3.09% | -0.29% | -0.44% | 0.43% | 0.5% | 1.21% |
| EBITDA | -68.5M | -277.5M | -347.4M | -504.5M | -283.9M | -134.8M | 45.8M |
| EBITDA Margin % | - | - | - | - | - | - | - |
| Interest Expense | 900K | 22.3M | 77.7M | 20M | 34.6M | 46.1M | 42.2M |
| Non-Operating Income | -900K | -22.3M | -77.7M | -20M | -34.6M | -46.1M | -42.2M |
| Pretax Income | -69.1M | -282.4M | -363M | -521.1M | -297.7M | -147.4M | 30.9M |
| Pretax Margin % | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | - | - | - | - | - | - | - |
| Net Income | -69.1M | -282.4M | -363M | -521.1M | -297.7M | -147.4M | 30.9M |
| Net Margin % | - | - | - | - | - | - | - |
| Net Income Growth % | - | -3.09% | -0.29% | -0.44% | 0.43% | 0.5% | 1.21% |
| EPS (Diluted) | -6.08 | -24.83 | -86.43 | -37.62 | -21.11 | -10.24 | 1.83 |
| EPS Growth % | - | -3.08% | -2.48% | 0.56% | 0.44% | 0.51% | 1.18% |
| EPS (Basic) | -6.08 | -24.83 | -86.43 | -37.62 | -21.11 | -10.24 | 1.96 |
| Diluted Shares Outstanding | 1.77M | 14.08M | 13.88M | 13.84M | 14.1M | 14.4M | 16.9M |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Assets | 216M | 728.6M | 1.76B | 1.32B | 1.31B | 1.35B | 1.5B |
| Asset Growth % | - | 2.37% | 1.42% | -0.25% | -0% | 0.03% | 0.11% |
| Total Investment Assets | 20.2M | 122.8M | 224.5M | 134.6M | 133.2M | 171.2M | 311.2M |
| Long-Term Investments | 20.2M | 122.8M | 224M | 129.9M | 128.8M | 166.8M | 306.8M |
| Short-Term Investments | 20.2M | 122.8M | 224M | 129.9M | 128.8M | 166.8M | 306.8M |
| Total Current Assets | 193.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 122.3M | 391.7M | 1.11B | 706M | 762.1M | 678.7M | 599.3M |
| Receivables | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | -679.9M | -1.7B | -1.24B | -1.23B | -1.27B | -1.39B |
| Goodwill & Intangibles | 1.5M | 6.6M | 9.6M | 12.5M | 16.3M | 19.2M | 22M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.5M | 6.6M | 9.6M | 12.5M | 16.3M | 19.2M | 22M |
| PP&E (Net) | 3.8M | 10.2M | 8.9M | 10.3M | 5.5M | 2.8M | 1.8M |
| Other Assets | -24M | -139.6M | -242.5M | -152.7M | -150.6M | -188.8M | -330.6M |
| Total Liabilities | 318.7M | 1.1B | 729.9M | 782.9M | 1.04B | 1.18B | 1.29B |
| Total Debt | 14.9M | 171.9M | 188.2M | 0 | 295.4M | 299M | 200.1M |
| Net Debt | -107.4M | -219.8M | -924.6M | -706M | -466.7M | -379.7M | -399.2M |
| Long-Term Debt | 4.9M | 171.9M | 188.2M | 0 | 295.4M | 299M | 200.1M |
| Short-Term Debt | 10M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 40.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 30.1M | 55.5M | 137.1M | 130.7M | 159.5M | 120M | 103.9M |
| Deferred Revenue | -6.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -40.1M | -56.4M | -147.3M | -130.7M | -166.8M | -127.9M | -103.9M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -4.9M | -171.9M | -188.2M | 0 | -295.4M | -299M | -200.1M |
| Total Equity | -102.7M | -374M | 1.03B | 536.4M | 277.1M | 165.7M | 203.7M |
| Equity Growth % | - | -2.64% | 3.76% | -0.48% | -0.48% | -0.4% | 0.23% |
| Shareholders Equity | -102.7M | -374M | 1.03B | 536.4M | 277.1M | 165.7M | 203.7M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -102.6M | -385M | -748M | -1.27B | -1.57B | -1.72B | -1.68B |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 600K | 5.6M | 400K | -5.8M | -2.5M | -2.3M |
| Return on Equity (ROE) | - | - | -1.1% | -0.66% | -0.73% | -0.67% | 0.17% |
| Return on Assets (ROA) | -0.32% | -0.6% | -0.29% | -0.34% | -0.23% | -0.11% | 0.02% |
| Equity / Assets | - | - | - | - | - | - | - |
| Debt / Equity | - | - | 0.18x | - | 1.07x | 1.80x | 0.98x |
| Book Value per Share | -57.95 | -26.56 | 74.38 | 38.74 | 19.65 | 11.51 | 12.05 |
| Tangible BV per Share | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -26.1M | -127.2M | -287.2M | -403.4M | -210.6M | -33.6M | 195.7M |
| Operating CF Growth % | - | -3.87% | -1.26% | -0.4% | 0.48% | 0.84% | 6.82% |
| Operating CF / Revenue % | - | - | - | - | - | - | - |
| Net Income | -69.1M | -282.4M | -363M | -521.1M | -297.7M | -147.4M | 30.9M |
| Depreciation & Amortization | 600K | 4.9M | 15.6M | 16.6M | 13.8M | 12.6M | 14.9M |
| Stock-Based Compensation | 100K | 1.4M | 3.7M | 28.1M | 45M | 34.7M | 22.3M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 300K | 29.6M | 112.2M | 20.7M | 16M | 13.8M | 39M |
| Working Capital Changes | 42M | 119.3M | -55.7M | 52.3M | 12.3M | 52.7M | 88.6M |
| Cash from Investing | -20.6M | -114M | -114.1M | 76.9M | -16.6M | -45.7M | -154.4M |
| Capital Expenditures | -1.2M | -6.6M | -1.8M | -4.6M | -10.1M | -200K | -400K |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -40.3M | -138.1M | -158.4M | -17M | -47.7M | -76M | -197.8M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -2.3M | -5.5M | -14.3M | -6.6M | 0 | -9.2M | -11.4M |
| Cash from Financing | 150.9M | 535.5M | 1.1B | -80.3M | 283.3M | -4.1M | -120.7M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -200K | 0 | 0 | 0 | 0 |
| Stock Issued | 0 | 0 | 1.1B | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 1000K | -1000K | -1000K | 1000K | 0 | -1000K |
| Other Financing | 100K | 11.9M | 2.1M | 3.2M | 300K | -1.1M | -15M |
| Net Change in Cash | 104.2M | 294.3M | 697.2M | -406.8M | 56.1M | -83.4M | -79.4M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 18.1M | 122.3M | 416.6M | 1.11B | 707M | 763.1M | 679.7M |
| Cash at End | 122.3M | 416.6M | 1.11B | 707M | 763.1M | 679.7M | 600.3M |
| Free Cash Flow | -29.6M | -139.3M | -303.3M | -414.6M | -220.7M | -43M | 183.9M |
| FCF Growth % | - | -3.71% | -1.18% | -0.37% | 0.47% | 0.81% | 5.28% |
| FCF Margin % | - | - | - | - | - | - | - |
| FCF per Share | -16.7 | -9.89 | -21.85 | -29.95 | -15.65 | -2.99 | 10.88 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Combined Ratio | 259.58% | 197.31% | 204.67% | 250.87% | 195.79% | 132.4% | 97.37% |
| Medical Cost Ratio | 124.02% | 128.77% | 104.09% | 115.03% | 110.36% | 83.27% | 71.35% |
| Return on Equity (ROE) | - | - | -110.27% | -66.43% | -73.19% | -66.58% | 16.73% |
| Return on Assets (ROA) | -31.99% | -59.79% | -29.15% | -33.82% | -22.62% | -11.08% | 2.17% |
| Equity / Assets | -47.55% | -51.33% | 58.58% | 40.66% | 21.11% | 12.3% | 13.62% |
| Book Value / Share | -57.95 | -26.56 | 74.38 | 38.74 | 19.65 | 11.51 | 12.05 |
| Debt / Equity | - | - | 0.18x | - | 1.07x | 1.80x | 0.98x |
| Revenue Growth | - | 570.21% | 19.5% | -0.4% | -10.02% | 46.4% | 158.57% |
Root, Inc. (ROOT) has a price-to-earnings (P/E) ratio of 39.4x. This suggests investors expect higher future growth.
Root, Inc. (ROOT) grew revenue by 158.6% over the past year. This is strong growth.
Yes, Root, Inc. (ROOT) is profitable, generating $57.1M in net income for fiscal year 2024 (2.6% net margin).
Root, Inc. (ROOT) has a return on equity (ROE) of 16.7%. This is reasonable for most industries.
Root, Inc. (ROOT) has a combined ratio of 97.4%. A ratio below 100% indicates underwriting profitability.